Federated Hermes’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.81M | Sell |
527,538
-145,110
| -22% | -$2.15M | 0.01% | 621 |
|
|
2025
Q1 | $12.1M | Buy |
672,648
+4,333
| +0.6% | +$77.6K | 0.03% | 517 |
|
|
2024
Q4 | $11.6M | Buy |
668,315
+44,500
| +7% | +$775K | 0.03% | 520 |
|
|
2024
Q3 | $8.73M | Buy |
623,815
+582,098
| +1,395% | +$8.14M | 0.02% | 607 |
|
|
2024
Q2 | $343K | Buy |
+41,717
| New | +$343K | ﹤0.01% | 1391 |
|
|
2023
Q4 | – | Sell |
-97,491
| Closed | -$872K | – | 2213 |
|
|
2023
Q3 | $872K | Buy |
+97,491
| New | +$872K | ﹤0.01% | 1156 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$21 | – | 2261 |
|
|
2022
Q4 | $21 | Sell |
1
-1,198
| -100% | -$25.2K | ﹤0.01% | 2140 |
|
|
2022
Q3 | $30K | Buy |
1,199
+419
| +54% | +$10.5K | ﹤0.01% | 1732 |
|
|
2022
Q2 | $20K | Sell |
780
-86,154
| -99% | -$2.21M | ﹤0.01% | 1768 |
|
|
2022
Q1 | $2.24M | Buy |
86,934
+35,822
| +70% | +$923K | 0.01% | 1010 |
|
|
2021
Q4 | $1.59M | Buy |
51,112
+47,971
| +1,527% | +$1.49M | ﹤0.01% | 1114 |
|
|
2021
Q3 | $76K | Sell |
3,141
-63,257
| -95% | -$1.53M | ﹤0.01% | 1809 |
|
|
2021
Q2 | $969K | Sell |
66,398
-248,419
| -79% | -$3.63M | ﹤0.01% | 1329 |
|
|
2021
Q1 | $7.86M | Buy |
314,817
+49,583
| +19% | +$1.24M | 0.02% | 730 |
|
|
2020
Q4 | $7.23M | Buy |
265,234
+196,422
| +285% | +$5.35M | 0.01% | 713 |
|
|
2020
Q3 | $1.27M | Buy |
68,812
+67,392
| +4,746% | +$1.24M | ﹤0.01% | 1157 |
|
|
2020
Q2 | $29K | Sell |
1,420
-88
| -6% | -$1.8K | ﹤0.01% | 1826 |
|
|
2020
Q1 | $22K | Buy |
+1,508
| New | +$22K | ﹤0.01% | 1778 |
|
|
2019
Q1 | – | Sell |
-98,485
| Closed | -$2.23M | – | 2230 |
|
|
2018
Q4 | $2.23M | Buy |
98,485
+4,990
| +5% | +$113K | 0.01% | 986 |
|
|
2018
Q3 | $2.69M | Buy |
93,495
+3,855
| +4% | +$111K | 0.01% | 992 |
|
|
2018
Q2 | $2.44M | Buy |
+89,640
| New | +$2.44M | 0.01% | 936 |
|